Five Prime Therapeutics, Inc.

CIK 1175505 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Five Prime Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 15, 2022SC 13G/A0001172661-22-000969
May 17, 2021SC 13G/A0001104659-21-068163
Apr 26, 202115-12B0001193125-21-131491
Apr 21, 2021EFFECT9999999995-21-001516
Apr 19, 202140001209191-21-027423
Apr 19, 202140001209191-21-027413
Apr 19, 202140001209191-21-027390
Apr 19, 202140001209191-21-027409
Apr 19, 202140001209191-21-027417
Apr 19, 202140001209191-21-027397
Apr 19, 202140001209191-21-027415
Apr 19, 202140001209191-21-027419
Apr 19, 202140001209191-21-027405
Apr 19, 202140001209191-21-027411
Apr 19, 202140001209191-21-027421
Apr 19, 202140001209191-21-027427
Apr 16, 2021SC 14D9/A0001193125-21-118574
Apr 16, 2021S-8 POS0001193125-21-119362
Apr 16, 2021POS AM0001193125-21-119305
Apr 16, 20218-K0001193125-21-118566
Apr 16, 2021SC TO-T/A0001193125-21-118568
Apr 16, 2021S-8 POS0001193125-21-119352
Apr 16, 2021S-8 POS0001193125-21-119330
Apr 16, 2021S-8 POS0001193125-21-119342
Apr 16, 202125-NSE0001354457-21-000482